We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Advanced Motion Management Technology Devised for the Treatment of Lung Cancer

By HospiMedica International staff writers
Posted on 15 Sep 2010
New technology monitors and adjusts for tumor motion during radiotherapy treatments.

Varian Medical Systems, Inc. More...
(Palo Alto, CA, USA) will display the company's new Gated RapidArc technology on its Trilogy machine with advanced motion management capabilities at the 2010 CHINA-HOSPEQ exhibition held in Beijing, China, August 19-21, 2010, by China's Ministry of Health. Varian, a world-leading manufacturer of medical technology for treating cancer and a supplier of X-ray imaging technology, will also exhibit its software for planning and for managing radiation therapy treatments.

"Our next-generation Gated RapidArc technology, which was introduced five months ago for the Trilogy and other Varian accelerators, enables clinicians to monitor and adjust for tumor motion during a RapidArc treatment,” said Xiaoyun Wang, managing director of Varian's oncology systems operations in Beijing. "This sophisticated new tool makes it possible to monitor patient breathing and compensate for tumor motion during lung cancer treatments. This Gated RapidArc approach can ‘gate' the beam--turn it on and off--in response to tumor motion during treatment, to target the tumor accurately and spare surrounding healthy tissues.

Varian software on display will include the Eclipse treatment planning system, which simplifies modern radiation therapy planning for all kinds of treatment, including three-dimensional (3D) conformal, intensity-modulated radiation therapy (IMRT), electron, proton, and brachytherapy treatment. "Eclipse helps doctors and physicists efficiently create and verify treatment plans that have been optimized for each patient,” said Mr. Wang.

The Aria oncology information system, a comprehensive information and image management system that aggregates patient data into a single, organized, oncology-specific medical chart that simplifies the treatment process so clinicians can focus on caring for patients.

Varian will also highlight the company's X-ray tubes and flat-panel digital X-ray image detectors, which are used for digital imaging in medical, dental, and other applications. "Customers appreciate the fact that our extensive inventory of X-ray products is serviced from our service center here in Beijing,” said Hsiao-Li Pan, manager of Varian's X-ray products distribution business in China.

Varian will also participate in a special China Health Forum being sponsored by the Chinese Ministry of Health (MOH). Burt Lang, global marketing director and head of market research for Varian's oncology systems business, will participate in a roundtable discussion by healthcare vendors in China.

"Varian is honored to participate in these important events, and we are committed to serving the medical community in China,” said Mr. Wang. "As part of this commitment, we established a manufacturing facility for medical equipment and a training center in Beijing three years ago, where we now produce and test high- and low-energy linear accelerators with image guidance and RapidArc capabilities for distribution within China and to other parts of the world, following Varian's stringent global quality management processes. In addition, we operate an education facility that provided training for over 200 Chinese clinical professionals in 2009. Varian technology has been well accepted by the radiation oncology community here, with over 300 linear accelerators in use at some 250 treatment centers to treat cancer of the brain, nasopharynx, lung, and prostate. We look forward to sharing our latest advances with clinical experts from over 1200 hospitals expected to attend this year's CHINA-HOSPEQ exhibition.”

Related Links:
Varian Medical Systems



Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Hypodermic Syringe
SurTract™ Safety Syringe
Rapid Sepsis Test
SeptiCyte RAPID
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: 123RF

AI Platform Screens for Amyloid Cardiomyopathy Using ECG Images

Amyloid cardiomyopathy is a heart disease caused by deposits of misfolded proteins in the cardiac muscle. It is often missed until patients develop serious complications such as heart failure.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.